Therma Bright: A New Approach to Skin Care

Therma Bright is a progressive medical device technology company. Currently, they're focusing on providing consumers with quality medical devices that …

Therma Bright cold sore

A medical device company with bright ideas

Therma Bright is a progressive medical device technology company. Currently, they're focusing on providing consumers with quality medical devices that address their dermatological needs.

Therma Bright has spent a significant investment in intellectual property and research and development. This is for its InterceptCS™- cold sore device, the Therozap™ insect device, and will soon invest in a novel pain relief device.  Its current product lines address cold sore treatment and prevention. It also addresses the treatment of pain, itch and inflammation related to mosquito, bee, spider, mite, and jellyfish bites or stings.

Further, the Company is in the research and development stage to develop a novel device for relief of pain. This will target pain associated with back, knee or other joint pain. Moreover, they're focused on building recurring revenue streams from its products and to incorporate intelligent technology such as AI or IoT.

Additionally, the Company holds patents pending and trademarks. These are for Therozap™ and the trademark InterceptCS™ along with regulatory approvals for its thermal therapy technology.

For more information on Therma Bright Inc. (TSX.V: THRM) please fill out the form below.

You might also like

Equiton: An Expert Approach to Alternative Investments
Finance
January 16, 2026

Equiton: An Expert Approach to Alternative Investments

Advisors looking to diversify client portfolios with alternatives turn to Private Canadian Apartments^ – an asset class, which has historically performed positively across varying market cycles*.

This is some text inside of a div block.
Moon River Moly: Advancing Canada's Strategic Molybdenum Supply
Metals & Mining
January 16, 2026

Moon River Moly: Advancing Canada's Strategic Molybdenum Supply

Moon River Moly is advancing two of Canada’s most promising molybdenum projects to meet growing global demand.

This is some text inside of a div block.
Invest Better with BMO ETFs: Canada’s Homegrown Leader in Innovation
ETFs
January 15, 2026

Invest Better with BMO ETFs: Canada’s Homegrown Leader in Innovation

For over 16 years, BMO ETFs has stood out as a trailblazer in the Canadian investment space, managing over $160 billion in assets and offering solutions designed by Canadians, for Canadians

This is some text inside of a div block.
Subscribe and receive the investor Info